vimarsana.com

Page 3 - பாராளுமன்றம் நின்று குழு ஆன் அறிவியல் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Streamlining COVID-19 vaccine supplies

Streamlining COVID-19 vaccine supplies The Central government asking the states to prioritise the second dose of COVID-19 vaccines is an indication that vaccination will slow down over the next couple of months due to shortage.   |  14 May 2021 5:30 AM GMT The Central government asking the states to prioritise the second dose of COVID-19 vaccines is an indication that vaccination will slow down over the next couple of months due to shortage. The Ministry of Health has written to all the States to prioritise the second dose over the first dose in a 70:30 ratio. Vaccination gathering fresh momentum will depend on vaccine companies ramping up production. The Central government has informed the Supreme Court that monthly vaccine production would be ramped up to more than 13 crore doses by July-end. The Parliamentary Standing Committee on Science and Technology, Environment, Forests and Climate Change recommended in March to strengthen efforts for ramping up the production capaci

Allow Virtual Parliamentary Committees : Trinamool Reiterates Again

Allow Virtual Parliamentary Committees : Trinamool Reiterates Again Allow Virtual Parliamentary Committees : Trinamool Reiterates Again Citing the confidentiality clause, the centre has said no to opposition requests in the past. Called mini-Parliament, these Committees hold the government accountable on micro-issues (File) New Delhi: The Trinamool Congress has written another letter, its third, to both Rajya Sabha Chairman Venkaiah Naidu and Lok Sabha Speaker Om Birla underscoring the need to hold virtual meetings of parliamentary committees as the deadly second wave of the coronavirus sweeping through a wide swathe of the country has been worsening the health crisis. Referred to as mini-Parliament, these Committees hold the government accountable on micro-issues.

Open up licensing to develop vaccines and accelerate vaccination drive, demand medical experts

Companies other than Bharat Biotech must be given contracts to manufacture the indigenously developed Covaxin in bulk. This is the time to open licensing to any company that wants to produce vaccines and for anyone who wants to take a jab, per doctors.

COVID: Jairam Ramesh urges parliamentary standing committees be allowed to meet virtually

URL copied Jairam Ramesh urges parliamentary standing committees be allowed to meet virtually. Senior Congress leader Jairam Ramesh on Tuesday demanded Rajya Sabha Chairman M Venkaiah Naidu and Lok Sabha Speaker Om Birla allow parliamentary standing committees to meet virtually to discuss issues of urgent public importance. Ramesh, the chairman of the Parliamentary Standing Committee on Science and Technology, Environment, Forests and Climate Change, has been calling for allowing the holding of Committee meetings virtually in view of the coronavirus pandemic. Naidu had earlier disallowed the request, citing rules and secrecy issues. I am requesting this once again for the umpteenth time. Speaker Lok Sabha Om Birla and Chairman Rajya Sabha M Venkaiah Naidu, please allow virtual meetings of Standing Committees. There are so many issues of utmost public importance that need to be discussed urgently, he said in a tweet.

How much vaccine can India make? And the catch

How much vaccine can India make? And the catch. PB Jayakumar and Vinay Rai © India Today Group How much vaccine can India make? And the catch. As coronavirus cases continue to rise in the country, the focus has  shifted to vaccination. India has administered over 10.45 crore doses of COVID-19 vaccines cumulatively as of Monday morning. But in the clamour against vaccine shortage, the question is what is the total vaccine production capacity and how many COVID-19 vaccines can India produce? The Department of Biotechnology had recently informed the Parliamentary Standing Committee on Science and Technology, Environment, Forests and Climate Change that the estimated manufacturing capacity of Covishield is 70-100 million doses every month, while Covaxin has a planned production capacity of 12.5 million a month (150 million doses a year). However, neither is producing to full capacity as vaccine makers say they are not earning enough to plough back into capacity

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.